Authors: Tam, RC Ramasamy, K Bard, J Pai, B Lim, C Averett, DR

Citation: Rc. Tam et al., The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviraleffects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels, ANTIM AG CH, 44(5), 2000, pp. 1276-1283

Authors: Wang, GY Tam, RC Gunic, E Du, JF Bard, J Pai, B

Citation: Gy. Wang et al., Synthesis and cytokine modulation properties of pyrrolo[2,3-d]-4-pyrimidone nucleosides, J MED CHEM, 43(13), 2000, pp. 2566-2574

Authors: Tam, RC Wu-Pong, S Pai, B Lim, C Chan, A Thomas, DF Milovanovic, T Bard, J Middleton, PJ

Citation: Rc. Tam et al., Increased potency of an aptameric G-rich oligonucleotide is associated with novel functional properties of phosphorothioate linkages, ANTISENSE N, 9(3), 1999, pp. 289-300

Authors: Tam, RC Pai, B Bard, J Lim, C Averett, DR Phan, UT Milovanovic, T

Citation: Rc. Tam et al., Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile, J HEPATOL, 30(3), 1999, pp. 376-382

Authors: Tam, RC Lin, CJ Lim, C Pai, B Stoisavljevic, V

Citation: Rc. Tam et al., Inhibition of CD28 expression by oligonucleotide decoys to the regulatory element in exon 1 of the CD28 gene, J IMMUNOL, 163(8), 1999, pp. 4292-4299

Authors: Tam, RC Lim, C Bard, J Pai, B

Citation: Rc. Tam et al., Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling, J IMMUNOL, 163(7), 1999, pp. 3709-3717